Marshall Wace, LLP Corcept Therapeutics Inc Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

A detailed history of Marshall Wace, LLP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 20,200 shares of CORT stock, worth $917,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,200

Previous 98,499 79.49%

Holding current value

$917,686

Previous $2.48 Million 73.56%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $1.74 Million - $2.7 Million	-78,299 Reduced 79.49%	20,200 $656,000
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $2.08 Million - $2.7 Million	98,499 New	98,499 $2.48 Million
Q3 2023 Nov 14, 2023	SELL	$21.97 - $33.8 $3.7 Million - $5.7 Million	-168,584 Reduced 89.85%	19,042 $518,000
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $1.4 Million - $1.65 Million	65,500 Added 53.63%	187,626 $4.17 Million
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $2.34 Million - $2.99 Million	122,126 New	122,126 $2.65 Million
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $632,221 - $745,355	-25,596 Reduced 46.57%	29,372 $753,000
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $780,317 - $1.14 Million	45,027 Added 452.94%	54,968 $1.31 Million
Q2 2021 Aug 13, 2021	SELL	$19.97 - $24.43 $725,649 - $887,712	-36,337 Reduced 78.52%	9,941 $219,000
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $4.82 Million - $6.27 Million	-205,122 Reduced 81.59%	46,278 $1.1 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $5.01 Million - $8.15 Million	-298,682 Reduced 54.3%	251,400 $6.58 Million
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $6.85 Million - $11 Million	550,082 New	550,082 $9.58 Million
Q2 2020 Aug 13, 2020	SELL	$11.0 - $18.26 $5.92 Million - $9.83 Million	-538,555 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $4.9 Million - $6.8 Million	484,178 Added 890.41%	538,555 $6.4 Million
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $2.84 Million - $4 Million	-235,809 Reduced 81.26%	54,377 $658,000
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $138,640 - $195,241	-13,318 Reduced 4.39%	290,186 $4.1 Million
Q2 2019 Aug 14, 2019	BUY	$9.78 - $12.76 $494,114 - $644,673	50,523 Added 19.97%	303,504 $3.38 Million
Q1 2019 May 14, 2019	SELL	$10.03 - $15.71 $3.22 Million - $5.04 Million	-320,855 Reduced 55.91%	252,981 $2.97 Million
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $5.15 Million - $7.85 Million	456,584 Added 389.4%	573,836 $7.67 Million
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $1.44 Million - $1.83 Million	117,252 New	117,252 $1.64 Million

Others Institutions Holding CORT

# of Institutions

311

Shares Held

88.3M

Call Options Held

1.07M

Put Options Held

973K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.87B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Corcept Therapeutics Inc Transaction History